{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T22:56:39Z","timestamp":1769640999476,"version":"3.49.0"},"reference-count":42,"publisher":"BMJ","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2010,5,12]]},"published-print":{"date-parts":[[2011,11]]},"abstract":"<jats:p>Heroin use in pregnancy is a worldwide problem. Methadone maintenance treatment has definite advantages for the mother and is currently recommended in the UK. There is, however, increasing evidence of adverse effects upon developing cortical and visual function in children of treated heroin-addicted mothers. The longer-term implications of this are not yet clear, and are confounded by poly-drug misuse and ongoing social deprivation. There is a paucity of evidence regarding outcome for infants who require pharmacological treatment for neonatal abstinence syndrome compared to those who have only mild symptoms. Well-controlled studies of the treatment of heroin misuse in pregnancy that take account of both neonatal and longer term outcomes for the child are urgently required.<\/jats:p>","DOI":"10.1136\/adc.2009.181057","type":"journal-article","created":{"date-parts":[[2010,6,28]],"date-time":"2010-06-28T23:44:57Z","timestamp":1277768697000},"page":"F457-F460","source":"Crossref","is-referenced-by-count":10,"title":["The management of heroin misuse in pregnancy: time for a rethink?"],"prefix":"10.1136","volume":"96","author":[{"given":"Helen","family":"Mactier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2010,6,28]]},"reference":[{"key":"2025090502191943000_96.6.F457.1","unstructured":"Heroin timeline. Heroin addiction drug rehab, 2010. Available at http:\/\/www.heroinaddiction.com\/heroin_timeline.html (Accessed 15 March 2010)."},{"key":"2025090502191943000_96.6.F457.2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1994.tb00896.x"},{"key":"2025090502191943000_96.6.F457.3","unstructured":"NHS Information Centre for Health and Social Care. Statistics and data collection. Available at http:\/\/www.ic.nhs.uk (Accessed 12 June 2010)."},{"key":"2025090502191943000_96.6.F457.4","unstructured":"NHS Services Scotland. Drug Misuse Statistics Scotland 2008 (published 16 Feb 2009). Available at http:\/\/www.audit-scotland.gov.uk\/docs\/\u2026\/nr_090326_drugs_alcohol.pdf (Accessed 15 March 2010)."},{"key":"2025090502191943000_96.6.F457.5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2008.02073.x"},{"key":"2025090502191943000_96.6.F457.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2005.08.010"},{"key":"2025090502191943000_96.6.F457.7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9310155312.x"},{"key":"2025090502191943000_96.6.F457.8","doi-asserted-by":"publisher","DOI":"10.1136\/adc.63.1.81"},{"key":"2025090502191943000_96.6.F457.9","doi-asserted-by":"crossref","unstructured":"Minozzi S Amato L Vecchi S . Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev 2008;2:CD006318.","DOI":"10.1002\/14651858.CD006318.pub2"},{"key":"2025090502191943000_96.6.F457.10","doi-asserted-by":"publisher","DOI":"10.1080\/10550490050172272"},{"key":"2025090502191943000_96.6.F457.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2008.02283.x"},{"key":"2025090502191943000_96.6.F457.12","first-page":"2S31","article-title":"[Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature]","volume":"153","author":"Loustauneau","year":"2002","journal-title":"Ann Med Interne (Paris)"},{"key":"2025090502191943000_96.6.F457.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1999.9422317.x"},{"key":"2025090502191943000_96.6.F457.14","doi-asserted-by":"publisher","DOI":"10.1159\/000113726"},{"key":"2025090502191943000_96.6.F457.15","doi-asserted-by":"publisher","DOI":"10.2174\/157015908784533842"},{"key":"2025090502191943000_96.6.F457.16","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1965.03090080008002"},{"key":"2025090502191943000_96.6.F457.17","unstructured":"UK Guidelines 2007. Department of Health (England), The Scottish Government, Welsh Assembly Government, Northern Ireland Executive, Drug Misuse and Dependence: UK Guideline on Clinical Management, 2007. http:\/\/www.smmgp.org.uk (Accessed 14 June 2010)."},{"key":"2025090502191943000_96.6.F457.18","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9345157.x"},{"key":"2025090502191943000_96.6.F457.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.1997.tb02877.x"},{"key":"2025090502191943000_96.6.F457.20","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2007.132985"},{"key":"2025090502191943000_96.6.F457.21","doi-asserted-by":"publisher","DOI":"10.1136\/adc.64.2.235"},{"key":"2025090502191943000_96.6.F457.22","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-200241140-00003"},{"key":"2025090502191943000_96.6.F457.23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2006.01321.x"},{"key":"2025090502191943000_96.6.F457.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.11.013"},{"key":"2025090502191943000_96.6.F457.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ntt.2009.09.001"},{"key":"2025090502191943000_96.6.F457.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainresbull.2003.11.004"},{"key":"2025090502191943000_96.6.F457.27","doi-asserted-by":"publisher","DOI":"10.1016\/0892-0362(92)90006-V"},{"key":"2025090502191943000_96.6.F457.28","doi-asserted-by":"publisher","DOI":"10.1016\/S0892-0362(97)00018-4"},{"key":"2025090502191943000_96.6.F457.29","doi-asserted-by":"publisher","DOI":"10.1002\/glia.20675"},{"key":"2025090502191943000_96.6.F457.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.earlhumdev.2007.01.013"},{"key":"2025090502191943000_96.6.F457.31","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(82)80115-7"},{"key":"2025090502191943000_96.6.F457.32","doi-asserted-by":"publisher","DOI":"10.1016\/0145-2134(96)00014-2"},{"key":"2025090502191943000_96.6.F457.33","doi-asserted-by":"publisher","DOI":"10.1017\/S0012162201001219"},{"key":"2025090502191943000_96.6.F457.34","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1542\/peds.75.2.269","article-title":"Factors affecting head growth and intellectual function in children of drug addicts","volume":"75","author":"Lifschitz","year":"1985","journal-title":"Pediatrics"},{"key":"2025090502191943000_96.6.F457.35","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1542\/peds.63.1.135","article-title":"The development of preschool children of heroin-addicted mothers: a controlled study","volume":"63","author":"Wilson","year":"1979","journal-title":"Pediatrics"},{"key":"2025090502191943000_96.6.F457.36","first-page":"367","article-title":"Ocular abnormalities in infants as sequelae of prenatal drug addiction","volume":"13","author":"Chavez","year":"1979","journal-title":"Pediatr Res"},{"key":"2025090502191943000_96.6.F457.37","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2008.156851"},{"key":"2025090502191943000_96.6.F457.38","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.169284"},{"key":"2025090502191943000_96.6.F457.39","doi-asserted-by":"publisher","DOI":"10.1080\/08035250310009329"},{"key":"2025090502191943000_96.6.F457.40","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.105569"},{"key":"2025090502191943000_96.6.F457.41","doi-asserted-by":"publisher","DOI":"10.1016\/0376-8716(86)90109-2"},{"key":"2025090502191943000_96.6.F457.42","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(98)00024-6"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/adc.2009.181057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T09:19:35Z","timestamp":1757063975000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/adc.2009.181057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6,28]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2011,10,12]]},"published-print":{"date-parts":[[2011,11]]}},"alternative-id":["10.1136\/adc.2009.181057"],"URL":"https:\/\/doi.org\/10.1136\/adc.2009.181057","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,6,28]]}}}